Check out BBC Entrepreneurial Training & Consulting’s list of Solicitation Dates to stay up to date with agency application periods!

If your small business is considering hiring an undergraduate, graduate student, postdoc or research scientist, the National Health, Lungs, and Blood Institute (NHLBI) has a limited number of administrative supplements to cover the salary of a new-hire through the NIH’s Administrative Supplement to Promote Diversity in the SBIR/STTR program. Applications are accepted on a rolling basis. See PA-21-345 for details and application instructions.  

Is your company developing innovative new technologies targeting heart, lung, blood, or sleep (HLBS)-focused complications of pregnancy? If so, the National Heart, Lung, and Blood Institute (NHLBI) is now participating in the NOSI for  Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001). The NHLBI is interested in projects focused on detecting, predicting, and/or monitoring HLBS disorders during pregnancy and/or the post-partum period, as well as projects that enhance the monitoring and management of women with existing HLBS-specific disorders and risk factors who enter pregnancy or are considering becoming pregnant.

Medical device innovators with active NHLBI small business grants are invited to apply to the National Institute for Biomedical Imaging and Bioengineering (NIBIB) C3i program! The 24-week C3i program provides participants with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). 

The teams will be guided through a series of lectures and interactive exercises, where they will pressure-test the commercial viability of ideas using universal business criteria as well as the unique requirements of medical device commercialization. Participants also work with experienced business advisors and subject matter experts who provide insights into the market sector, intellectual property, regulatory, and reimbursement requirements specific to their projects. Applications for this year’s C3i cohort are due August 5^th, 2022. For more information, visit the NIBIB C3i Program website.  

Check out BBC Entrepreneurial Training & Consulting’s list of Solicitation Dates to stay up to date with agency application periods!

If your small business is considering hiring an undergraduate, graduate student, postdoc or research scientist, the National Health, Lungs, and Blood Institute (NHLBI) has a limited number of administrative supplements to cover the salary of a new-hire through the NIH’s Administrative Supplement to Promote Diversity in the SBIR/STTR program. Applications are accepted on a rolling basis. See PA-21-345 for details and application instructions.  

Is your company developing innovative new technologies targeting heart, lung, blood, or sleep (HLBS)-focused complications of pregnancy? If so, the National Heart, Lung, and Blood Institute (NHLBI) is now participating in the NOSI for  Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001). The NHLBI is interested in projects focused on detecting, predicting, and/or monitoring HLBS disorders during pregnancy and/or the post-partum period, as well as projects that enhance the monitoring and management of women with existing HLBS-specific disorders and risk factors who enter pregnancy or are considering becoming pregnant.

Medical device innovators with active NHLBI small business grants are invited to apply to the National Institute for Biomedical Imaging and Bioengineering (NIBIB) C3i program! The 24-week C3i program provides participants with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). 

The teams will be guided through a series of lectures and interactive exercises, where they will pressure-test the commercial viability of ideas using universal business criteria as well as the unique requirements of medical device commercialization. Participants also work with experienced business advisors and subject matter experts who provide insights into the market sector, intellectual property, regulatory, and reimbursement requirements specific to their projects. Applications for this year’s C3i cohort are due August 5^th, 2022. For more information, visit the NIBIB C3i Program website.  

Check out BBC Entrepreneurial Training & Consulting’s list of Solicitation Dates to stay up to date with agency application periods!

If your small business is considering hiring an undergraduate, graduate student, postdoc or research scientist, the National Health, Lungs, and Blood Institute (NHLBI) has a limited number of administrative supplements to cover the salary of a new-hire through the NIH’s Administrative Supplement to Promote Diversity in the SBIR/STTR program. Applications are accepted on a rolling basis. See PA-21-345 for details and application instructions.  

Is your company developing innovative new technologies targeting heart, lung, blood, or sleep (HLBS)-focused complications of pregnancy? If so, the National Heart, Lung, and Blood Institute (NHLBI) is now participating in the NOSI for  Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001). The NHLBI is interested in projects focused on detecting, predicting, and/or monitoring HLBS disorders during pregnancy and/or the post-partum period, as well as projects that enhance the monitoring and management of women with existing HLBS-specific disorders and risk factors who enter pregnancy or are considering becoming pregnant.

Medical device innovators with active NHLBI small business grants are invited to apply to the National Institute for Biomedical Imaging and Bioengineering (NIBIB) C3i program! The 24-week C3i program provides participants with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). 

The teams will be guided through a series of lectures and interactive exercises, where they will pressure-test the commercial viability of ideas using universal business criteria as well as the unique requirements of medical device commercialization. Participants also work with experienced business advisors and subject matter experts who provide insights into the market sector, intellectual property, regulatory, and reimbursement requirements specific to their projects. Applications for this year’s C3i cohort are due August 5^th, 2022. For more information, visit the NIBIB C3i Program website.  

Check out BBC Entrepreneurial Training & Consulting’s list of Solicitation Dates to stay up to date with agency application periods!

If your small business is considering hiring an undergraduate, graduate student, postdoc or research scientist, the National Health, Lungs, and Blood Institute (NHLBI) has a limited number of administrative supplements to cover the salary of a new-hire through the NIH’s Administrative Supplement to Promote Diversity in the SBIR/STTR program. Applications are accepted on a rolling basis. See PA-21-345 for details and application instructions.  

Is your company developing innovative new technologies targeting heart, lung, blood, or sleep (HLBS)-focused complications of pregnancy? If so, the National Heart, Lung, and Blood Institute (NHLBI) is now participating in the NOSI for  Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001). The NHLBI is interested in projects focused on detecting, predicting, and/or monitoring HLBS disorders during pregnancy and/or the post-partum period, as well as projects that enhance the monitoring and management of women with existing HLBS-specific disorders and risk factors who enter pregnancy or are considering becoming pregnant.

Medical device innovators with active NHLBI small business grants are invited to apply to the National Institute for Biomedical Imaging and Bioengineering (NIBIB) C3i program! The 24-week C3i program provides participants with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). 

The teams will be guided through a series of lectures and interactive exercises, where they will pressure-test the commercial viability of ideas using universal business criteria as well as the unique requirements of medical device commercialization. Participants also work with experienced business advisors and subject matter experts who provide insights into the market sector, intellectual property, regulatory, and reimbursement requirements specific to their projects. Applications for this year’s C3i cohort are due August 5^th, 2022. For more information, visit the NIBIB C3i Program website.  

Check out BBC Entrepreneurial Training & Consulting’s list of Solicitation Dates to stay up to date with agency application periods!

If your small business is considering hiring an undergraduate, graduate student, postdoc or research scientist, the National Health, Lungs, and Blood Institute (NHLBI) has a limited number of administrative supplements to cover the salary of a new-hire through the NIH’s Administrative Supplement to Promote Diversity in the SBIR/STTR program. Applications are accepted on a rolling basis. See PA-21-345 for details and application instructions.  

Is your company developing innovative new technologies targeting heart, lung, blood, or sleep (HLBS)-focused complications of pregnancy? If so, the National Heart, Lung, and Blood Institute (NHLBI) is now participating in the NOSI for  Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001). The NHLBI is interested in projects focused on detecting, predicting, and/or monitoring HLBS disorders during pregnancy and/or the post-partum period, as well as projects that enhance the monitoring and management of women with existing HLBS-specific disorders and risk factors who enter pregnancy or are considering becoming pregnant.

Medical device innovators with active NHLBI small business grants are invited to apply to the National Institute for Biomedical Imaging and Bioengineering (NIBIB) C3i program! The 24-week C3i program provides participants with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). 

The teams will be guided through a series of lectures and interactive exercises, where they will pressure-test the commercial viability of ideas using universal business criteria as well as the unique requirements of medical device commercialization. Participants also work with experienced business advisors and subject matter experts who provide insights into the market sector, intellectual property, regulatory, and reimbursement requirements specific to their projects. Applications for this year’s C3i cohort are due August 5^th, 2022. For more information, visit the NIBIB C3i Program website.